slotkoers
Korea S.E.
00:00:00 28-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
9.020
KRW
|
+1,12%
|
|
+1,35%
|
-0,55%
|
Fiscaal tijdperk: december |
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
123.682
|
126.612
|
115.658
|
138.068
|
Bedrijfswaarde
1 |
160.400
|
169.245
|
155.754
|
197.683
|
K/w-verhouding
|
-9,5
x
|
209
x
|
94,5
x
|
34,5
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
2,65
x
|
1,93
x
|
1,33
x
|
1,46
x
|
Bedrijfswaarde/omzet
|
3,43
x
|
2,57
x
|
1,79
x
|
2,1
x
|
Bedrijfswaarde/EBITDA
|
-17,5
x
|
58,3
x
|
17,6
x
|
40,5
x
|
Bedrijfswaarde/FCF
|
-35.707.082
x
|
-13.882.600
x
|
30.045.841
x
|
-6.416.045
x
|
FCF Yield
|
-0%
|
-0%
|
0%
|
-0%
|
Price to Book
|
4,82
x
|
4,03
x
|
3,92
x
|
2,49
x
|
Aantal aandelen (in duizenden)
|
13.629
|
14.226
|
14.226
|
15.222
|
Referentieprijs
2 |
9.075
|
8.900
|
8.130
|
9.070
|
Datum van publicatie
|
22/03/21
|
22/03/22
|
21/03/23
|
20/03/24
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
60.362
|
46.717
|
65.741
|
87.087
|
94.335
|
EBITDA
1 |
10.181
|
-9.167
|
2.904
|
8.869
|
4.884
|
Bedrijfsresultaat (EBIT)
1 |
7.629
|
-11.975
|
331,5
|
5.586
|
428,7
|
Operationele Marge
|
12,64%
|
-25,63%
|
0,5%
|
6,41%
|
0,45%
|
Resultaat voor belastingen (EBT)
1 |
2.225
|
-16.528
|
90,96
|
1.363
|
2.780
|
Nettowinst (verlies)
1 |
442,3
|
-13.252
|
606,7
|
1.229
|
3.835
|
Nettomarge
|
0,73%
|
-28,37%
|
0,92%
|
1,41%
|
4,07%
|
WPA
2 |
35,00
|
-955,0
|
42,64
|
86,00
|
262,9
|
Free Cash Flow
|
-
|
-4.492
|
-12.191
|
5.184
|
-30.811
|
FCF-marge
|
-
|
-9,62%
|
-18,54%
|
5,95%
|
-32,66%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
58,45%
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
421,81%
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
22/03/21
|
22/03/21
|
22/03/22
|
21/03/23
|
20/03/24
|
Fiscaal tijdperk: december |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q3
|
---|
Omzet
|
12,64
|
22,09
|
23,84
|
23,59
|
17,57
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
|
-2,081
|
3,325
|
3,253
|
2,209
|
-3,2
|
-
|
Operationele Marge
|
-16,47%
|
15,05%
|
13,64%
|
9,36%
|
-18,21%
|
-
|
Resultaat voor belastingen (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettowinst (verlies)
1 |
-
|
-
|
-
|
-
|
-8,694
|
1,423
|
Nettomarge
|
-
|
-
|
-
|
-
|
-49,48%
|
-
|
WPA
2 |
-
|
-
|
-
|
-
|
-
|
96,00
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
11/03/22
|
16/05/22
|
12/08/22
|
11/11/22
|
13/03/23
|
10/11/23
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
30.471
|
36.718
|
42.633
|
40.097
|
59.615
|
Nettokaspositie
1 |
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
2,993
x
|
-4,005
x
|
14,68
x
|
4,521
x
|
12,21
x
|
Free Cash Flow
|
-
|
-4.492
|
-12.191
|
5.184
|
-30.811
|
ROE (netto-inkomsten/eigen vermogen)
|
-
|
-43,6%
|
0,41%
|
0,94%
|
5,6%
|
ROA (netto-inkomsten/totale activa)
|
-
|
-8,15%
|
0,2%
|
2,83%
|
0,17%
|
Totale activa
1 |
-
|
162.536
|
302.287
|
43.479
|
2.281.222
|
Nettoactief per aandeel
2 |
40.895
|
1.882
|
2.211
|
2.073
|
3.644
|
Cashflow per aandeel
2 |
6.539
|
297,0
|
426,0
|
554,0
|
1.127
|
Capex
1 |
1.746
|
4.985
|
8.280
|
4.967
|
26.349
|
Capex/omzet
|
2,89%
|
10,67%
|
12,59%
|
5,7%
|
27,93%
|
Datum van publicatie
|
22/03/21
|
22/03/21
|
22/03/22
|
21/03/23
|
20/03/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -0,55% | 101 mln. | | +13,31% | 129 mld. | | -10,21% | 10,92 mld. | | -2,59% | 8,5 mld. | | +37,50% | 5,5 mld. | | -22,36% | 4,69 mld. | | -11,25% | 2,73 mld. | | -14,85% | 2 mld. | | -13,29% | 1,93 mld. | | -28,75% | 1,65 mld. |
Medische hulpmiddelen & implantaten
|